First Horizon Advisors, Inc. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 263 filers reported holding SAGE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
First Horizon Advisors, Inc. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21
-55.3%
10.0%0.00%
Q2 2023$47
+11.9%
10.0%0.00%
Q1 2023$42
+10.5%
10.0%0.00%
Q4 2022$3810.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$01
-93.3%
0.00%
Q1 2022$0
-100.0%
15
-71.2%
0.00%
Q4 2021$2,0000.0%520.0%0.00%
Q3 2021$2,000
+100.0%
52
+173.7%
0.00%
Q2 2021$1,00019
+90.0%
0.00%
Q1 2021$0
-100.0%
10
-95.6%
0.00%
-100.0%
Q4 2019$16,000
-48.4%
2260.0%0.00%
-50.0%
Q3 2019$31,000
-22.5%
2260.0%0.00%
-33.3%
Q2 2019$40,000
+14.3%
2260.0%0.00%0.0%
Q1 2019$35,000
+105.9%
226
+25.6%
0.00%
+50.0%
Q4 2018$17,000
-29.2%
1800.0%0.00%0.0%
Q3 2018$24,000
-11.1%
1800.0%0.00%0.0%
Q2 2018$27,000
+237.5%
180
+221.4%
0.00%
+100.0%
Q1 2018$8,000560.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,966,688$120,204,00010.81%
Integral Health Asset Management, LLC 230,000$14,058,0004.30%
Asymmetry Capital Management, L.P. 102,462$6,262,0004.02%
ACUTA CAPITAL PARTNERS, LLC 225,000$13,752,0003.74%
DAFNA Capital Management LLC 158,306$9,676,0003.14%
Bain Capital Life Sciences Investors, LLC 499,100$30,505,0002.84%
Boxer Capital, LLC 1,094,000$66,865,0002.31%
Palo Alto Investors LP 590,200$36,073,0001.98%
Logos Global Management LP 250,000$15,280,0001.96%
Bellevue Group AG 1,579,504$96,539,0001.33%
View complete list of SAGE THERAPEUTICS INC shareholders